Rick Simpson Oil (RSO) in Grayson County, Kentucky: The Complete Guide by OilWell Cannabis

If you’re living in Grayson County, Kentucky — whether you’re tending cattle near Rough River, working a shift at one of Leitchfield’s manufacturing plants, or caring for family in the rolling hills of the Pennyroyal Plateau — you’ve probably heard whispers about Rick Simpson Oil. Maybe a neighbor mentioned it at the feed store. Maybe you saw a post in a local Facebook group. Maybe you’re one of the thousands of Kentuckians searching for alternatives to prescription painkillers, struggling with sleepless nights, or supporting a loved one through cancer treatment.

We get it. Out here in Grayson County, where the nearest specialist might be an hour away in Louisville or Bowling Green, where the opioid crisis has hit our community hard, and where traditional medicine doesn’t always have answers for chronic pain or PTSD, people are looking for real solutions. That’s why we’re reaching out directly to you in Grayson County — not with hype, not with promises we can’t keep, but with the most comprehensive, honest, and scientifically grounded RSO education available anywhere.

Who Is Rick Simpson? The Man Behind the Oil That Changed Cannabis Forever

Rick Simpson wasn’t a doctor. He wasn’t a scientist. He was a power engineer from Amherst, Nova Scotia — a blue-collar tradesman who, like many folks in Grayson County, believed in practical solutions and straight talk. In 1997, while working at a hospital in Moncton, Simpson fell from scaffolding and suffered a severe head injury. The aftermath left him with persistent tinnitus, dizziness, and post-concussion symptoms that the medical system couldn’t fix. The medications doctors prescribed either didn’t help or made things worse. When he asked his physician about cannabis, the door was shut in his face.

Sound familiar? In Grayson County, we’ve seen this story play out too many times — hardworking people injured on the job, left with chronic pain, and told prescription pills are the only option. Simpson’s frustration with a system that offered him no alternatives is exactly what drives so many Kentuckians to explore cannabis today.

Simpson’s path took a turn in 2003 when three bumps on his arm were diagnosed as basal cell carcinoma. Rather than follow conventional treatment, he applied concentrated cannabis oil directly to the lesions, covered them with bandages, and claimed they disappeared within four days. No biopsy confirmation. No independent medical verification. No peer-reviewed documentation. But this personal experience — whether you view it as a miracle, a misunderstanding, or something in between — became the origin story of Rick Simpson Oil and sparked a global movement .

Why Simpson’s Story Matters for Grayson County

We share this history not because we think it’s proof RSO cures cancer (it’s not), but because it explains why you’re hearing about RSO in the first place. Before the 2018 Farm Bill, before hemp became legal in Kentucky, before dispensaries opened in Louisville — there was Rick Simpson, giving his oil away for free to cancer patients and teaching people how to make it themselves. He helped dozens of people with conditions that plague our community: chronic pain, diabetes, glaucoma, arthritis, depression, insomnia. He wrote a book called Phoenix Tears and maintained phoenixtears.ca as a free resource .

In Grayson County, where we’ve lost too many neighbors to prescription opioid addiction, where veterans come home with PTSD and can’t get the help they need, where cancer patients face grueling drives to Louisville for treatment — Simpson’s story resonates. He was a man who said, “If the system won’t help you, I’ll give you the tools to help yourself.” That ethos of accessibility and empowerment is exactly what we built OilWell Cannabis around.

The Traditional RSO Protocol: What Simpson Actually Recommended

Simpson’s core protocol was simple in concept and massive in execution: consume 60 grams of concentrated cannabis oil over approximately 90 days. Here’s exactly how he laid it out :

Week 1: Start with a dose the size of half a grain of rice — about 10-15mg of oil — taken three times daily. That’s roughly 30-45mg total per day.

Weeks 2-5: Double the dose every four days. By week five, you’re consuming about 1 gram (1,000mg) of oil per day, divided into three doses.

Weeks 5-12: Maintain 1 gram per day until you finish all 60 grams.

Administration: Primary route was oral (sublingual or swallowed). For skin cancers, he recommended topical application with a bandage, changed every 3-4 days. He discouraged inhalation as a primary treatment method.

Tolerance: Simpson claimed patients develop tolerance to THC’s psychoactive effects within 3-4 weeks, and that the “high” becomes a minor side effect.

Post-protocol: After completing 60 grams, he recommended a maintenance dose of 1-2 grams per month indefinitely.

The Reality Check: Why This Protocol Is Problematic Today

If you’re in Grayson County reading this, you need to know the full picture before anyone tells you to follow Simpson’s protocol:

• No clinical validation. Not a single randomized controlled trial, cohort study, or well-documented case series supports this specific 60-gram/90-day protocol for any cancer type or condition. Zero.
• Massive THC exposure. At peak dosing (1 gram of 60-90% THC oil), you’re consuming 600-900mg of delta-9 THC daily. That’s 30-450 times the typical dose of FDA-approved THC medication (2.5-20mg). At those levels, you’re facing severe intoxication, anxiety, panic, tachycardia, and cannabis use disorder risks [1][13][14][15].
• Unstandardized material. Traditional RSO was crude, tar-like oil made with naphtha or isopropyl alcohol. Every batch was different. No lab testing. No Certificate of Analysis. No consistency.
• Real risks. Cancer patients in Grayson County are medically complex. Using unregulated, untested cannabis oil as a primary treatment — potentially instead of proven therapies — can cause irreversible harm.

We say this clearly: Do not replace proven cancer treatment with RSO. The evidence doesn’t support cure claims, and delaying surgery, radiation, chemo, or immunotherapy can be deadly. If you’re dealing with cancer in Grayson County, please coordinate with your oncologist at Hardin Memorial Hospital in Elizabethtown, the James Graham Brown Cancer Center in Louisville, or your local healthcare provider. RSO should complement medical care, not replace it.

What Traditional RSO Actually Was: The Product Specifications

Traditional RSO wasn’t a standardized medicine — it was a homemade extract with serious limitations:

Source material: Single high-THC indica strain, no standardization. Whatever you grew or could source locally around Leitchfield or Caneyville.

Extraction solvent: Naphtha (lighter fluid) or 99% isopropyl alcohol. Neither is food-grade. Naphtha contains benzene, toluene, and other carcinogens. Incomplete purging leaves toxic residues.

Process: Bucket, solvent, agitate, filter, rice cooker evaporation. The heat destroyed terpenes and fully decarboxylated everything, converting all THCa to THC.

Appearance: Nearly black, thick, tar-like, with possible solvent-residual smell.

Cannabinoid profile: 60-90% delta-9 THC, minor cannabinoids at natural ratios (uncontrolled, unmeasured, never lab-verified).

Terpenes: Minimal to none. The solvent and heat stripped them out.

Standardization: None. Every batch differed based on plant material, growing conditions, extraction technique, and who made it.

Residual solvent risk: Significant. Without lab testing, you couldn’t verify if naphtha or isopropyl alcohol remained in the final product.

Simpson’s Claims vs. The Evidence: What We Know Today

Simpson claimed RSO could cure cancer, diabetes, chronic pain, infections, glaucoma, arthritis, depression, insomnia, MS, and more . Let’s look at what the evidence actually shows:

What Simpson Was NOT

• Not a scientist, physician, pharmacist, or researcher
• Never conducted or published a clinical trial
• Never submitted results to peer review
• Evidence base: personal experience and testimonials only

What Preclinical Research Shows

• Laboratory and animal studies show THC and CBD can induce apoptosis (cell death), inhibit tumor proliferation, and reduce angiogenesis in certain cancer cell lines .
• Animal models show some tumor-growth inhibition in rodents .
• Important: These findings have NOT translated to proven human cancer cures. The gap between lab results and human outcomes is vast.

What Human Clinical Trials Show

• No human clinical trial has demonstrated RSO or any cannabis oil cures cancer.
• Small exploratory trials in glioblastoma haven’t produced cure-level results .
• The U.S. National Cancer Institute acknowledges cannabinoid anticancer research but does NOT endorse cannabis as cancer treatment .
• FDA has NOT approved any cannabis plant product for cancer. Only purified CBD (Epidiolex) and synthetic THC analogues (dronabinol, nabilone) are approved for specific non-cancer indications [1].

What Simpson Got Right

He drew attention to cannabinoids as serious biomedical research when the world was ignoring them. He helped create the political and cultural conditions for today’s legal cannabis industry. The term “RSO” remains the most recognized name for full-spectrum cannabis extract. That historical contribution is real and significant.

What He Overstated

Cure claims exceeded the evidence then and still do today. Encouraging cancer patients to use RSO instead of proven therapies carries genuine harm potential. Delayed treatment is a documented concern in alternative medicine literature. In Grayson County, where we already face healthcare access challenges, this is especially dangerous.

The Legacy: Why “RSO” Means Different Things Today

The term RSO has become generic. Walk into any dispensary in Louisville or Lexington, and “RSO” on a label might mean almost any full-spectrum extract — regardless of extraction method, cannabinoid profile, or quality. It often bears little resemblance to what Simpson actually made .

Simpson himself has been critical of commercial products using the RSO name while departing from his method. He believed in a DIY, free-access model — grow your own cannabis, make your own oil, give it away. The modern cannabis industry has done the opposite: commercialized, standardized, and regulated what he distributed for free.

The philosophical tension: Was Simpson’s free-distribution model the pure expression of patient empowerment, or was it a necessary response to prohibition that modern legalization improves upon through quality control and safety testing? We think it’s both. That’s why we built OilWell Cannabis around a rare middle ground: we sell a professional, lab-tested product, AND we publish the complete open-source formula so you can make it yourself if you can’t afford ours.

Traditional RSO vs. Modern Formulated RSO: The Complete Comparison

For our neighbors in Grayson County trying to navigate this confusing market, here’s the side-by-side breakdown:

Dimension	Traditional Simpson RSO	OilWell Formulated RSO
Source Material	Single high-THC indica strain	Multi-cannabinoid blend from multiple hemp sources
Extraction Solvent	Naphtha or isopropyl alcohol (toxic, non-food-grade)	Modern food-grade ethanol or CO₂ (no solvents in final product)
Cannabinoid Profile	THC-dominant (60-90%), uncontrolled, unmeasured	Seven defined cannabinoids at specific ratios: CBD 4,500mg, CBG 3,000mg, Delta-8 6,000mg, THCa 1,500mg, Delta-9 90mg, CBN 750mg, CBC 750mg
Terpenes	Destroyed by heat (minimal to none)	Live terpenes at 5%: limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene
Standardization	None — every batch different	Lab-tested with Certificates of Analysis (COA)
Lab Testing	Not performed	Full panel: potency, terpenes, pesticides, heavy metals, residual solvents, microbes
Residual Solvents	Significant risk with naphtha	Controlled and tested — solvent-free final product
Dosing Precision	Approximate (“grain of rice”)	Measured at 553mg per mL with graduated dropper (0.1mL increments)
Product Formats	Single thick oil only	Sublingual oil AND vape cartridge, each optimized for different needs
THCa Preservation	No — fully decarboxylated	Yes — 1,500mg THCa as separate ingredient, customer-controlled activation
Evidence Approach	Anecdotal, personal testimony	Research-backed, evidence-weighted with 29 peer-reviewed citations

Why OilWell’s Formulas Diverge from Traditional RSO (And Why That Matters for Grayson County)

We didn’t just tweak Simpson’s recipe — we reimagined it from the ground up based on what modern science actually tells us. Here’s why each divergence matters for you in Grayson County:

1. Multi-Cannabinoid Approach

Traditional RSO used whatever single strain you grew. In Grayson County, where growing cannabis is still illegal recreationally and medical access is limited, that model doesn’t work. Our formula includes seven cannabinoids because the entourage-effect literature [20][29] suggests broader therapeutic potential through cannabinoid diversity. For chronic pain patients in Leitchfield, for veterans with PTSD in Clarkson, for seniors with arthritis in Caneyville — multiple pathways matter.

2. Terpene Preservation

Simpson’s heat destroyed terpenes. We include live terpenes at 5% because preclinical literature shows plausible bioactivity [20]-[28]. For Grayson County residents who appreciate the natural aromas of our region — the pine forests, the blooming wildflowers, the fresh-cut hay — terpenes connect the product to the sensory experiences you already trust.

3. THCa as a Separate Ingredient

Traditional RSO forced psychoactivity. We preserve 1,500mg of THCa in its raw, non-psychoactive form because the THCa literature suggests anti-inflammatory and neuroprotective activity that disappears when heated [12]. For our neighbors in Grayson County who work construction, drive trucks, or operate farm equipment, this means daytime relief without impairment.

4. Reduced Delta-9 THC Dominance

Simpson’s oil was 60-90% delta-9 THC. Our formula contains only 90mg total delta-9 THC (3mg/mL) — well below the 0.3% Farm Bill threshold. We distribute the remaining cannabinoid content across CBD, CBG, delta-8, CBN, and CBC. This reflects modern research showing that high-dose THC isn’t always the answer, especially given the mental health risks documented in recent high-concentration THC studies [15].

5. Product Format Innovation

Simpson had one format. We have two: a 30mL sublingual oil for sustained relief and a 1g vape cartridge for acute breakthrough moments. For Grayson County residents managing chronic conditions, this flexibility matters — different situations call for different tools.

Solvent Safety: Why Traditional Extraction Methods Are Dangerous

Traditional RSO used naphtha (lighter fluid) or isopropyl alcohol. Naphtha contains benzene, toluene, and other carcinogens. Isopropyl alcohol isn’t food-grade. Without lab equipment, you can’t verify if these toxic solvents remain in your final oil.

In Grayson County, where many people still consider DIY approaches, this is critical safety information. Making RSO at home with solvents is dangerous — fire risk, explosion risk, toxic residue risk. We’ve seen too many accidents in rural communities where well-meaning people got hurt.

Modern production uses food-grade ethanol or supercritical CO₂. Our product contains NO extraction solvents in the final formula — it’s a blend of individual cannabinoid distillates in organic MCT oil. Every batch is tested for residual solvents using headspace gas chromatography. For Grayson County residents who value product safety and transparency, this is the standard you should demand.

The Decarboxylation Choice: Why THCa Changes Everything

Here’s where modern chemistry meets patient empowerment. Traditional RSO fully decarboxylated everything — all THCa converted to delta-9 THC through heat. You had no choice about psychoactivity.

Our formula includes 1,500mg of THCa as a distinct ingredient. This creates three usage options for Grayson County customers:

Option 1: Raw (Non-Psychoactive)
Use the oil as-is. All 1,500mg stays as THCa. You get potential anti-inflammatory benefits via COX-2 inhibition and neuroprotective effects via PPARγ agonism [12], with zero psychoactive impairment. Perfect for daytime use while working your farm, operating machinery, or caring for family in Grayson County.

Option 2: Fully Activated (Home Decarboxylation)
Heat the oil at 260°F for 45-60 minutes in an oven-safe glass container. This converts 1,500mg THCa → ~1,315mg delta-9 THC. Combined with the existing 90mg delta-9 THC, you get ~1,405mg total delta-9 THC. Combined with 6,000mg delta-8 THC, this achieves psychoactive potency comparable to traditional illegal RSO — 100% legally, because YOU control the activation after purchase.

Option 3: Partial Decarboxylation
Convert only what you need. Transfer a portion to a separate container, decarboxylate it, and leave the rest raw. This gives you precise control over potency per dose.

For Grayson County residents who need relief around the clock, this means one product serves multiple needs: raw for daytime function, activated for nighttime relief.

The OilWell Story: From a Paralyzed Dog to Serving Grayson County

OilWell Cannabis didn’t start in a corporate boardroom. It started in Houston, Texas, with a dog named Bentley — and that story matters for every customer in Grayson County.

Bentley was more than a pet. He was family. When veterinarians said Bentley was paralyzed in his hind legs and the only humane option was euthanasia, Colin Valencia refused to accept it. The pain medications would destroy Bentley’s organs. The choice was painful decline or death.

But Bentley was a fighter. And Colin had already seen too much suffering growing up in McAllen, Texas — a border town plagued by violence and economic hardship. He’d lost friends to prison and death. He wasn’t losing Bentley too.

In desperation, a rescue worker named Jessica asked Colin: “You’ve moved how many tons of weed and you’ve never heard of CBD?” That question changed everything.

Colin created a CBD golden paste formula for Bentley. The result wasn’t just improvement — it was a miracle. Bentley got up, walked across the room, and brought Colin his ball to play. From paralyzed to playing fetch. Dogs don’t respond to placebo. This was real.

Bentley lived another ten years, dying naturally at age twenty. During those years, Colin developed specialized formulas for every condition Bentley faced:

• Neurodegeneration → CBG for neuroprotection, THCa for PPARγ agonism
• Dementia → CBC for neurogenesis
• Glaucoma → THC for intraocular pressure
• Arthritis → Multi-pathway anti-inflammatory approach using CBD, CBG, THCa, and beta-caryophyllene

Single cannabinoids weren’t enough. Bentley’s evolving conditions required multi-cannabinoid synergy. That lesson — born from keeping a loved one alive — became the foundation of OilWell’s RSO formula.

From Dog to Human: Colin’s Personal Battle

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to quit Xanax cold turkey — one of the most difficult and dangerous feats — he used the same cannabinoid knowledge that saved Bentley.

The Peace Gummies formula that OilWell sells was created during midnight experiments while fighting through benzo withdrawal. Colin personally uses the vape form to manage his insomnia and severe PTSD. This isn’t theoretical knowledge. He lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills don’t.

For Grayson County residents dealing with addiction, PTSD, or chronic pain, this matters. You’re not buying from a corporation. You’re buying from people who’ve been in the trenches.

Building Products Doctors Trust

Over time, the therapeutic benefits Colin discovered through Bentley became the core of his work. He’s developed formulas that doctors use for:

• Crohn’s disease, IBS, ulcerative colitis
• PTSD and benzodiazepine addiction
• Insomnia and sleep disorders
• Vegan and diabetic-specific needs

We make products that healthcare providers in the Texas Medical Center — the world’s largest medical complex — trust for their patients. That same quality and precision is what we offer to Grayson County.

ABC13 Houston: Seven Features, Four Years, One Voice

Between 2019 and 2023, ABC13 Houston (KTRK) — the ABC affiliate serving America’s fourth-largest city — featured Colin Valencia and OilWell Cannabis in seven distinct news segments. Five different reporters sought us out across those years. No other Houston cannabis operator has that frequency or breadth of coverage.

Why does this matter for Grayson County? Because mainstream media validation from a major-market ABC affiliate is a credibility signal that transcends geography. When you’re deciding whether to trust a cannabis company from Houston, knowing that we’ve been vetted by professional journalists over four years — covering business, law, medicine, community health, and politics — tells you we’re not a fly-by-night operation.

Here are the highlights:

September 2019: “Texas CBD businesses booming”
Our first feature. Colin’s foundational quote: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.” This principle guides everything we do.

March 2021: “Entrepreneur creates direct-to-consumer business”
Featured our ecosystem support for other entrepreneurs like Jonathan Pina. Colin’s quote: “People think that everyone just wants to get high… but people are looking for things to help them with real pain. Pain comes in a lot of different forms.” In Grayson County, you know this truth intimately.

May 2021: “What is Delta-8 THC”
Steve Campion’s investigative piece featured the iconic exchange:
Campion: “Why would someone want to smoke that?”
Colin: “I don’t give a sh** if it’s wrong to say you’ll get high off it. Maybe you want to get high.”
Radical honesty on mainstream TV. That’s our approach.

August 2021: “Houston CBD shop giving away free products for COVID vaccine”
We gave away 1,000 caviar pre-rolls (worth ~$35,000) to encourage vaccination. We coordinated with the City of Houston. No political agenda. Just community health. That’s who we are.

October 2021: “Texas ban over once legal hemp product Delta-8”
When Texas DSHS classified Delta-8 as Schedule I overnight, we proactively removed all products before enforcement and warned other operators who were unknowingly shipping narcotics. We absorbed a major revenue loss to act ethically. That’s leadership.

October 2022: “Biden marijuana pardon — experts weigh in on why Texas won’t see impact”
This feature revealed Colin’s personal marijuana conviction history. His quote: “I would love to see people not get hurt for this anymore.” Every other quote carries more weight when you know the person saying it has lived the consequences.

April 2023: “Marijuana industry getting creative as Texas laws continue to change”
Colin’s “Renaissance” framing: “Right now is actually a pretty important time that should be enjoyed now.” We see opportunity where others see obstacles.

These features are not marketing materials. They’re independently produced, editorially controlled news segments from a major ABC affiliate that repeatedly identified us as Houston’s most credible cannabis voice. That recognition cannot be purchased — it can only be earned.

The OilWell RSO Philosophy: Four Core Principles for Grayson County

Our approach isn’t about hype. It’s about solving real problems for real people in places like Grayson County:

1. Accessibility Over Gatekeeping

No medical card required. Age 21+ only. We ship nationwide and internationally to customers who verify local legality. In Kentucky, where the medical cannabis program is still developing and dispensaries are limited to a handful of locations (none in Grayson County), this matters. You don’t have to drive to Louisville or wait for Kentucky’s program to mature. You can order from your home in Leitchfield, Caneyville, or Clarkson and have it delivered.

2. Patient-Controlled Potency

THCa is sold in its acidic, non-psychoactive form. YOU decide whether to use it raw for daytime relief without impairment or decarboxylate it into delta-9 THC for full psychoactive effects. For Grayson County residents who work in agriculture, manufacturing, or healthcare — jobs where impairment is not an option — this control is essential.

3. Open-Source Formulas

We publish our complete formulas publicly. If you can’t afford $129.99 for our sublingual oil, you can see exactly what’s in it and source the ingredients yourself. This is our echo of Simpson’s free-distribution ethos, adapted for modern Grayson County where economic challenges are real and hemp-derived cannabinoids are legally accessible.

4. Evidence-Informed, Not Evidence-Overstated

We commit to honest education about what science actually says. The GENERAL KNOWLEDGE section of this document (which we’ll get to) contains 29 peer-reviewed citations evaluating every cannabinoid and terpene in our formula. We distinguish between what’s well-supported, what’s emerging, and what’s overstated. In Grayson County, where medical resources are stretched and misinformation spreads fast, this honesty is critical.

Farm Bill Compliance and Kentucky Legality: What Grayson County Residents Need to Know

The 2018 Farm Bill legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC at the federal level. This is the legal foundation that makes OilWell’s products available to you in Grayson County.

Our RSO Sublingual Oil contains only 90mg of delta-9 THC in the entire 30mL bottle (3mg/mL) — well under the 0.3% threshold. All cannabinoids are hemp-derived. The product is legal under federal law and in Kentucky.

THCa is the game-changer. THCa (tetrahydrocannabinolic acid) is the non-psychoactive precursor to delta-9 THC. At the point of sale, it’s Farm Bill compliant because it hasn’t been converted. But here’s what matters for Grayson County:

When you heat THCa at 260°F (125°C) for 45-60 minutes, it converts to delta-9 THC. The conversion ratio is 1mg THCa → 0.877mg delta-9 THC (accounting for CO₂ loss).

Our 1,500mg THCa converts to ~1,315mg delta-9 THC. Combined with the existing 90mg delta-9 THC, you get ~1,405mg total delta-9 THC when activated. Combined with 6,000mg delta-8 THC, this achieves psychoactive potency comparable to traditional illegal RSO — 100% legally, because YOU control the activation.

Important legal notice: Kentucky law mirrors federal Farm Bill requirements. However, THCa conversion to delta-9 THC through heating changes the legal status. Customers are responsible for understanding and complying with local laws. We ship with full documentation, COAs, and receipts. International customers accept all customs and legal risk.

For Grayson County residents, this means you can legally purchase, possess, and use our products in their raw form. If you choose to decarboxylate, you’re activating THC in the privacy of your own home — a personal medical decision, not a commercial one.

Open-Source Formulas: Why We Give Away Our Secrets

In a county like Grayson, where the median household income is below the national average and many families are living paycheck to paycheck, we know our $129.99 sublingual oil might be out of reach for some. That’s why we published the complete formula — every cannabinoid, every milligram amount, every percentage.

If you can’t afford our product, you can source cannabinoid distillates and isolates from hemp suppliers and make your own version. We want you to have options. This isn’t a marketing gimmick. It’s our commitment to accessibility.

We even published the original CBD golden paste recipe that saved Bentley’s life, because we know pet owners in Grayson County face the same heart-wrenching decisions Colin did:

CBD Golden Paste Recipe:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1-2 tsp freshly ground black pepper (for absorption)
• CBD oil (dosage depends on pet size; consult a vet)

Instructions: Mix turmeric and water over low heat until thick paste forms (7-10 minutes). Add coconut oil and pepper. Cool, refrigerate up to 2 weeks. Mix with pet food 1-2x daily. This is the formula that got Bentley up and walking.

For Grayson County pet owners, this is free, actionable information that could save your companion’s life.

Solvent-Free Production: Why Our Method Is Safer

We don’t extract with solvents. We formulate by blending individual cannabinoid distillates and isolates in a controlled production environment. No naphtha. No butane. No isopropyl alcohol.

The carrier is organic MCT oil — a food-grade lipid that facilitates sublingual absorption and provides neutral taste. No tar-like consistency. No solvent-residual odor. Just clean, tested oil.

Third-party lab testing covers:

• Cannabinoid potency (±2% accuracy)
• Terpene profile
• Pesticides (400+ compound screening)
• Heavy metals (arsenic, cadmium, lead, mercury)
• Residual solvents (FDA Class 3 limits <5,000 ppm)
• Microbial contaminants (E. coli, Salmonella, Aspergillus)

Certificates of Analysis are available on our website and shipped with every order. For Grayson County residents who’ve heard horror stories about contaminated products, this is the transparency you deserve.

Two Product Formats: Choosing What’s Right for Your Grayson County Lifestyle

We offer the RSO formula in two delivery systems, each designed for different situations you’ll encounter in Grayson County:

RSO Sublingual Oil — $129.99

• 30mL bottle (1 fl oz)
• 16,590mg total cannabinoids (553mg/mL)
• Seven cannabinoids: CBD 4,500mg, CBG 3,000mg, Delta-8 6,000mg, THCa 1,500mg, Delta-9 90mg, CBN 750mg, CBC 750mg
• 5% live terpenes
• Organic MCT oil base
• Graduated dropper: 0.1mL increments for precise dosing
• Onset: 15-45 minutes (sublingual)
• Peak: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Doses per bottle: 40-60 depending on serving size

Best for: Sustained relief throughout your workday in Grayson County, managing chronic pain during a full shift, sleep support through the night, or precise control over your daily regimen.

RSO Vape Cartridge — $49.99

• 1-gram cartridge
• 900mg+ total cannabinoids
• Same six-cannabinoid ratio (auto-decarboxylates THCa at vaping temperature)
• 5%+ live terpenes
• 510-thread universal battery (compatible with standard vape batteries available in Grayson County)
• Onset: 1-2 minutes (fastest delivery)
• Peak: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%

Best for: Acute breakthrough pain while working on your property, anxiety attacks, nausea episodes, or any situation where you need immediate relief in Grayson County.

When to Use Each Format

Your Grayson County Situation	Recommended Format	Why
Working a 12-hour shift at the plant	Sublingual (raw)	Non-psychoactive, sustained relief
Sudden back pain while farming	Vape	1-2 minute onset for acute pain
Trouble sleeping in rural quiet	Sublingual (decarbed)	4-6 hour duration with CBN
Driving to Louisville for treatment	Vape	Portable, discreet, immediate
Precise daily regimen	Sublingual	Graduated dropper for accuracy
Daytime anxiety without impairment	Sublingual (raw)	THCa stays non-psychoactive
Nighttime full relief	Sublingual (decarbed) or Vape	Activated THCa + delta-8 THC

Condition-Specific Guidance for Grayson County Residents

IMPORTANT DISCLAIMER: The following contexts are informed by research cited in our GENERAL KNOWLEDGE section. These are NOT medical prescriptions, NOT FDA-approved protocols, and NOT substitutes for professional medical care. Always consult your healthcare provider at Twin Lakes Regional Medical Center in Leitchfield, your primary care physician, or a specialist before using cannabinoid products. Individual results vary. Do not operate vehicles or machinery while under the influence.

Chemotherapy-Related Nausea & Appetite Support

• Pre-chemo: 0.5-1.0mL sublingual 1 hour before treatment at James Graham Brown Cancer Center
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief
• Post-chemo: 0.5mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0mL sublingual before bed (delivers 25-50mg CBN)
• Evidence: Delta-8 antiemetic [9], Delta-9 nausea control [1][13], CBD anxiety buffering [3]

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

• Daytime: 0.3-0.5mL raw sublingual — anti-inflammatory without impairment while working
• Nighttime: 0.5-1.0mL decarbed sublingual — pain relief + CBN sleep support
• Breakthrough pain: Vape as needed
• Evidence: CBD pain relief [4], Delta-9 pain control [13], beta-caryophyllene CB2 activation [24], THCa COX-2 inhibition [12]

Sleep Support

• Before bed: 1.0-2.0mL sublingual
• At 2.0mL = 50mg CBN (the dosage investigated in 2024 sleep literature)
• At 1.0mL = 25mg CBN (above threshold for reduced sleep disturbance)
• Evidence: CBN sleep research [16][17]

Anxiety & Stress

• Daytime functional relief: 0.3mL raw sublingual — CBD + CBG without impairment
• Nighttime: 1.0mL sublingual — full profile with CBN
• Evidence: CBD anxiety reduction [3], CBG pharmacology [7][8], limonene entourage effects [20]

General Titration Principle for Grayson County

Start low, go slow. Begin with 0.25-0.5mL sublingual. Assess effects over 2-3 hours before increasing. Your body weight, metabolism, tolerance, and medications all affect response. In Grayson County’s close-knit community, talk to others who’ve tried it, but remember: your experience is your own.

Delivery to Grayson County: How You Get Our Products

We ship nationwide to all 50 states where Farm Bill-compliant products are legal — including Kentucky and Grayson County. Here’s how it works:

Shipping to Grayson County, KY:

• USPS Priority Mail: 2-3 business days to Leitchfield, Caneyville, Clarkson, or your rural route
• FedEx/UPS Ground: 3-5 business days
• Discreet packaging: No cannabis branding visible on exterior
• Tracking provided: You’ll know exactly when it arrives
• Temperature-stable packaging: Protects product during Kentucky summers
• Signature-required option: Available for security

Cost: Standard shipping rates apply. We do not currently offer same-day delivery to Grayson County (that’s limited to Houston), but we process orders within 24 hours.

Documentation included:

• Full Certificate of Analysis (COA) for your batch
• Receipt with legal product description
• Usage guidance and decarboxylation instructions
• Legal compliance documentation

For Grayson County residents concerned about privacy, rest assured: our packaging is plain, and our company name appears as “OilWell CBD” on shipping labels.

How OilWell Formulas Connect to Scientific Evidence

Every cannabinoid in our formula — CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC — has its own evidence profile in our GENERAL KNOWLEDGE section (see below). Every terpene — limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene — is evaluated with peer-reviewed citations.

When we claim CBD has anxiolytic potential, we cite the 2024 systematic review and meta-analysis [3]. When we discuss delta-8 THC, we reference the comparative pharmacology review [9]. When we mention CBN for sleep, we acknowledge the 2021 narrative review that found no robust clinical trials [16].

This document doesn’t exempt us from the same evidence standards we apply to the broader field. We hold ourselves accountable because Grayson County residents deserve nothing less.

GENERAL KNOWLEDGE: The Science Behind Every Compound

Research Method and Evidence Weighting

We prioritize evidence in this order: human clinical trials, systematic reviews/meta-analyses, NIH/institutional summaries, then preclinical/mechanistic studies. This matters because the evidence base is uneven. CBD and delta-9 THC have the strongest human data; delta-8, THCa, CBG, CBN, CBC, and terpenes rely more on reviews and animal studies [1]-[29].

Institutional Baseline from NIH

• Strongest evidence: Rare epilepsies (CBD), chemo nausea (THC), HIV/AIDS appetite (THC) [1]
• Modest evidence: Chronic pain, multiple sclerosis symptoms [1]
• FDA approvals: Purified CBD (Epidiolex) and synthetic THC analogues (dronabinol, nabilone) — NOT cannabis plant itself [1]
• Safety concerns: Impairment, motor vehicle crashes, cannabis use disorder, pregnancy risks, contamination, labeling inaccuracy, vape lung injury [1]

Cannabinoid Evidence Profiles

CBD (Cannabidiol)

• Strongest evidence: Seizure disorders [1][2]
• Anxiety: 2024 systematic review (316 participants) showed significant anxiolytic signal but limited clinical sample [3]
• Pain: 2024 systematic review found promising but heterogeneous results, limiting broad analgesic claims [4]
• Sleep: 2023 insomnia review found methodologically weak studies, mostly subjective measures [5]
• Safety: 2023 meta-analysis found liver enzyme elevation and possible drug-induced liver injury, especially with concentrated oral products [6]
• Bottom line: Most evidence-developed nonintoxicating cannabinoid, but strong evidence is indication-specific, not generalized wellness [1]-[6]

CBG (Cannabigerol)

• Evidence: Mostly review-level and preclinical; human evidence sparse [7][8]
• Pharmacology: Precursor to major cannabinoids; interacts with cannabinoid receptors, alpha-2 adrenoceptors, 5-HT1A pathways [7]
• Research areas: Neurologic disorders, inflammatory bowel disease, antibacterial activity — primarily preclinical hypotheses [7][8]
• Caution: Commercially sold while evidence base remains thin; claims often outrun science [7]
• Bottom line: Promising minor cannabinoid with limited clinical validation [7][8]

Delta-8 THC

• Evidence: Pharmacologically relevant, psychoactive, less clinically characterized than delta-9 [9]-[11]
• Pharmacology: Partial CB1 agonist, cannabimimetic activity, less potent than delta-9 due to weaker CB1 affinity [9]
• Public health: 2023 scoping review found evidence dominated by animal studies, chemistry, use reports; noted adverse consequences and regulatory concerns [10]
• Manufacturing: Commercial interest tied to greater stability and easier synthesis; product-byproduct and lab-testing questions matter [11]
• Bottom line: Psychoactive THC analogue with real activity, incomplete human safety characterization, manufacturing-quality uncertainties [9]-[11]

THCa (Tetrahydrocannabinolic Acid)

• Evidence: Important chemically, low on direct human therapeutic evidence [12]
• What it is: Acidic precursor to THC; represents large share of raw plant THC content
• Key issue: Decarboxylates to THC during heating and storage; interpretation depends on route, temperature, processing [12]
• Research: In vitro and rodent studies suggest anti-inflammatory (COX-2), immunomodulatory, neuroprotective (PPARγ), antineoplastic possibilities — NOT established human outcomes [12]
• Bottom line: Highly relevant precursor whose interpretation depends heavily on conditions; any claim must account for possible THC conversion [12]

Delta-9 THC

• Evidence: Strongest of psychoactive cannabinoids, but clearest adverse-effect burden [1][13]-[15]
• Institutional support: NCCIH identifies relevance for chemo nausea, HIV/AIDS appetite, some MS/pain outcomes — many uses remain uncertain [1]
• Pain: 2022 systematic review found high-THC or balanced THC:CBD products may provide short-term pain benefit but increase dizziness, sedation, nausea, discontinuation [13]
• Pharmacokinetics: Inhaled onset seconds-minutes, peak 15-30 min, duration few hours; oral onset later, peak later, duration longer [14]
• Mental health risk: 2025 systematic review found consistent unfavorable associations with psychosis/schizophrenia and cannabis use disorder; concerning signals for anxiety/depression in nontherapeutic settings [15]
• Safety: Anxiety/panic at high doses, tachycardia, hypotension, dependency, withdrawal, pregnancy concerns, accidental pediatric exposure, vape lung injury [1][14][15]
• Bottom line: Legitimate therapeutic relevance in some settings, but carries clearest intoxication, psychiatric, and dose-related safety liabilities [1][13]-[15]

CBN (Cannabinol)

• Evidence: Weak human evidence; marketing ahead of data [12][16][17]
• Reputation: Marketed for sleep/sedation, but clinical support far thinner than market suggests [16][17]
• Sleep review: 2021 narrative review screened 99 human-study abstracts, reviewed 8 full-text articles — found NO clinical trials using validated sleep questionnaires or polysomnography to substantiate strong sleep claims [16]
• Broader sleep literature: 2024 updated review concluded cannabinoid sleep research doesn’t match real-world use scale; need for better-designed, adequately powered trials remains substantial [17]
• Chemical context: THC degrades toward CBN under certain conditions; explains CBN discussion in aging/oxidized cannabis [12]
• Bottom line: Cultural reputation stronger than clinical evidence base [16][17]

CBC (Cannabichromene)

• Evidence: Emerging, intriguing, overwhelmingly preclinical/review-based [18][19]
• Pharmacology: 2024 focused review describes distinct pharmacodynamics, pharmacokinetics, receptor behavior; highlights antinociceptive, antibacterial, anti-seizure as interesting research targets [18]
• Older literature: Review of animal/in vitro work reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesia, possible neurobiological/antiproliferative relevance — NOT strong evidence for patient claims [19]
• Safety caveat: 2024 CBC review explicitly notes over-the-counter CBC products sold despite little evidence establishing clinical efficacy or safety [18]
• Bottom line: Scientifically credible minor cannabinoid deserving more research, not already-validated clinical active [18][19]

Terpene Evidence Profiles

Important framing: Terpene claims need stricter interpretation than cannabinoids. Most literature from isolated compounds, essential oils, non-cannabis plants, or preclinical models. 2024 entourage-effect review: terpene bioactivity plausible but robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Limonene

• Evidence: Review and preclinical; safety literature useful [20]-[22]
• Activity: 2021 review describes antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory possibilities — mostly from nonhuman/non-cannabis literature [21]
• Safety: Limonene oxidation products (hydroperoxides) are clinically relevant contact allergens, important in patch-testing [22]
• Bottom line: Biologically active, widely discussed, but cannabis-specific therapeutic claims should stay conservative [20]-[22]

Myrcene

• Evidence: Mostly preclinical, very limited human [20][23]
• Research: 2021 review describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties, possible mechanisms — explicitly states human studies lacking [23]
• Interpretation caution: Often invoked as proven sedative explaining “couch-lock” — stronger claim than current human evidence supports [20][23]
• Bottom line: Plausible bioactive terpene, but compound-specific clinical claims about mood/pain/sedation far ahead of definitive human proof [23]

Caryophyllene (β-caryophyllene)

• Evidence: Mechanistically interesting due to direct cannabinoid-system relevance, mostly preclinical [24]
• Why it stands out: 2021 focused review describes selective CB2 receptor agonist activity — unusual, making it especially relevant pharmacologically [24]
• Research themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective — human clinical confirmation limited [24]
• Bottom line: Strongest candidate terpene with cannabinoid-system significance, but still not clinically proven for commonly attributed outcomes [24]

Pinene

• Evidence: Promising preclinical, weak human confirmation [20][25]
• Brain health: 2021 review on pinene/linalool as terpene medicines found antioxidant, anti-inflammatory, neuroprotective signals justifying future study, but emphasized lack of well-designed human trials [25]
• Interpretation caution: Claims that pinene improves memory, sharpens attention, counterbalances THC cognitive effects remain interesting hypotheses, not settled clinical facts [20][25]
• Bottom line: Deserves scientific attention, but strong cognition claims should be presented as exploratory [25]

Linalool

• Evidence: Substantial preclinical interest, limited direct clinical confirmation [20][22][25][26]
• Research: Repeatedly discussed for stress, mood, brain health. 2021 brain-health review found enough preclinical signal to justify continued neurological/psychiatric investigation, while stressing lack of robust human trials [25]
• Additional literature: Separate reviews discuss antidepressant mechanisms, neuropharmacologic relevance — remains translational rather than definitive clinical story [26]
• Safety: Oxidized linalool hydroperoxides recognized allergens in dermatitis literature [22]
• Bottom line: Scientifically credible bioactive terpene, current evidence supports cautious phrasing rather than firm therapeutic promises [22][25][26]

Humulene

• Evidence: Translationally interesting, early-stage [20][27]
• Scoping review: 2024 review analyzed 340 articles, found broad preclinical anti-inflammatory evidence, some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27]
• Interpretation caution: Findings valuable for hypothesis generation, don’t establish consistent human efficacy across pain/inflammation/mood outcomes [27]
• Bottom line: Interesting research target, far from clinically settled [27]

Terpinolene

• Evidence: Least clinically characterized in this list [20][28]
• Systematic review: 2021 review screened 2,449 records, included 57 studies, concluded range of reported biological effects but evidence base dominated by in silico, in vitro, animal studies rather than human trials [28]
• Interpretation caution: Even recent cannabis entourage reviews frame terpene benefits as exploratory, not established compound-specific clinical effects [20]
• Bottom line: Biologically interesting, especially underdeveloped clinically among listed terpenes [20][28]

Research Limits and Interpretation

1. Evidence base is highly uneven. CBD and delta-9 THC support most detailed human-facing statements; rest require more caution [1]-[29].
2. Data categories aren’t interchangeable. Whole-cannabis extract, purified molecule, semisynthetic cannabinoid, and terpene-only data differ significantly. Common error: letting evidence from one category stand in for another.
3. Minor cannabinoids/terpenes are commercially interesting because underexplored — but this means claims often become inflated.
4. Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, route-dependent pharmacokinetics all materially affect real-world interpretation [1][10][11][14].
5. THCa chemistry is destiny: storage and heating change exposure profile by converting acidic cannabinoids to neutral (THC) [12].

Common Overstatements to Avoid (And What to Say Instead)

• Wrong: “CBN is a clinically proven sleep cannabinoid.”
  Right: “Specific sleep evidence for CBN remains weak; no strong validated trial base identified yet” [16][17].

• Wrong: “Myrcene is a proven human sedative causing couch-lock.”
  Right: “Myrcene has plausible preclinical bioactivity, but direct human proof for this common claim is limited” [20][23].

• Wrong: “Terpenes have proven entourage effects in patients.”
  Right: “Entourage hypotheses are influential and worth studying, but robust clinical proof remains limited and highly compound-specific” [20][29].

• Wrong: “THCa is always nonpsychoactive.”
  Right: “THCa itself isn’t THC, but heating/processing converts THCa to THC, changing effective exposure” [12].

• Wrong: “Delta-8 THC is safe because it’s hemp-derived.”
  Right: “Delta-8 THC is psychoactive, pharmacologically close to delta-9, and often entangled with manufacturing/testing concerns” [9]-[11].

Practical Takeaways for Our Formulas

• Most evidence-developed: CBD and delta-9 THC
• Delta-8 THC: Not trivial or purely mild; psychoactive with less robust safety/efficacy characterization than delta-9
• THCa: Meaningfully changes with processing; don’t interpret raw vs. heated formats the same way
• CBG/CBN/CBC: Scientifically credible but clinically immature compared to CBD/THC
• Terpenes: Likely relevant to aroma/flavor/possible bioactivity, but compound-specific human therapeutic claims require direct support

References [1]-[29]

1. National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH. Accessed March 2026. Available at: https://www.nccih.nih.gov/health/cannabis-marijuana-and-cannabinoids-what-you-need-to-know
2. Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Exp Neurol. 2023;359:114238. PMID: 36206805.
3. Han K, Wang JY, Wang PY, Peng YC. Therapeutic potential of cannabidiol CBD in anxiety disorders: A systematic review and meta-analysis. Psychiatry Res. 2024;339:116049. PMID: 38924898.
4. Cásedas G, Yarza-Sancho M, López V. Cannabidiol CBD: A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals Basel. 2024;17(11):1438. PMID: 39598350.
5. Ranum RM, Whipple MO, Croghan I, Bauer B, Toussaint LL, Vincent A. Use of cannabidiol in the management of insomnia: A systematic review. Cannabis Cannabinoid Res. 2023;8(2):213-229. PMID: 36149724.
6. Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023;293(6):724-752. PMID: 36912195.
7. Nachnani R, Raup-Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021;376(2):204-212. PMID: 33168643.
8. Li S, Li W, Malhi NK, Huang J, Li Q, Zhou Z, Wang R, Peng J, Yin T, Wang H. Cannabigerol CBG: A comprehensive review of its molecular mechanisms and therapeutic potential. Molecules. 2024;29(22):5471. PMID: 39598860.
9. Tagen M, Klumpers LE. Review of delta-8-tetrahydrocannabinol delta8 THC: Comparative pharmacology with delta9 THC. Br J Pharmacol. 2022;179(15):3915-3933. PMID: 35523678.
10. LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY. Delta-8 tetrahydrocannabinol: A scoping review and commentary. Addiction. 2023;118(6):1011-1028. PMID: 36710464.
11. Abdel-Kader MS, Radwan MM, Metwaly AM, Eissa IH, Hazekamp A, ElSohly MA. Chemistry and pharmacology of Delta-8-Tetrahydrocannabinol. Molecules. 2024;29(6):1249. PMID: 38542886.
12. Moreno-Sanz G. Can You Pass the Acid Test? Critical review and novel therapeutic perspectives of delta9-Tetrahydrocannabinolic Acid A. Cannabis Cannabinoid Res. 2016;1(1):124-130. PMID: 28861488.
13. McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R. Cannabis-based products for chronic pain: A systematic review. Ann Intern Med. 2022;175(8):1143-1153. PMID: 35667066.
14. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-360. PMID: 12648025.
15. Rittiphairoj T, Leslie L, Oberste JP, Yim TW, Tung G, Bero L, Riggs P, Hutchison K, Samet J, Li T. High-concentration delta-9-tetrahydrocannabinol cannabis products and mental health outcomes: A systematic review. Ann Intern Med. 2025;178(10):1429-1440. PMID: 40854216.
16. Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366-371. PMID: 34468204.
17. Lavender I, Garden G, Grunstein RR, Yee BJ, Hoyos CM. Using cannabis and CBD to sleep: An updated review. Curr Psychiatry Rep. 2024;26(12):712-727. PMID: 39612156.
18. Sepulveda DE, Vrana KE, Kellogg JJ, Bisanz JE, Desai D, Graziane NM, Raup-Konsavage WM. The potential of cannabichromene as a therapeutic agent. J Pharmacol Exp Ther. 2024;391(2):206-213. PMID: 38777605.
19. Zagožen M, Čerenak A, Kreft S. Cannabigerol and cannabichromene in Cannabis sativa L. Acta Pharm. 2021;71(3):355-364. PMID: 36654096.
20. André R, Gomes AP, Pereira-Leite C, Marques-da-Costa A, Monteiro Rodrigues L, Sassano M, Rijo P, Costa MDC. The entourage effect in cannabis medicinal products: A comprehensive review. Pharmaceuticals Basel. 2024;17(11):1543. PMID: 39598452.
21. Anandakumar P, Kamaraj S, Vanitha MK. D-limonene: A multifunctional compound with potent therapeutic effects. J Food Biochem. 2021;45(1):e13566. PMID: 33289132.
22. Ogueta IA, Brared Christensson J, Giménez-Arnau E, Brans R, Wilkinson M, Stingeni L, Foti C, Aerts O, Svedman C, Gonçalo M, Giménez-Arnau A. Limonene and linalool hydroperoxides review: Pros and cons for routine patch testing. Contact Dermatitis. 2022;87(1):1-12. PMID: 35122274.
23. Surendran S, Qassadi F, Surendran G, Lilley D, Heinrich M. Myrcene: What are the potential health benefits of this flavouring and aroma agent? Front Nutr. 2021;8:699666. PMID: 34350208.
24. Hashiesh HM, Sharma C, Goyal SN, Sadek B, Jha NK, Al Kaabi J, Ojha S. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of beta-caryophyllene, a dietary cannabinoid. Biomed Pharmacother. 2021;140:111639. PMID: 34091179.
25. Weston-Green K, Clunas H, Jimenez Naranjo C. A review of the potential use of pinene and linalool as terpene-based medicines for brain health: Discovering novel therapeutics in the flavours and fragrances of cannabis. Front Psychiatry. 2021;12:583211. PMID: 34512404.
26. Dos Santos ÉRQ, Maia JGS, Fontes-Júnior EA, do Socorro Ferraz Maia C. Linalool as a therapeutic and medicinal tool in depression treatment: A review. Curr Neuropharmacol. 2022;20(6):1073-1092. PMID: 34544345.
27. Dalavaye N, Nicholas M, Pillai M, Erridge S, Sodergren MH. The clinical translation of alpha-humulene: A scoping review. Planta Med. 2024;90(9):664-674. PMID: 38626911.
28. Menezes IO, Scherf JR, Martins AOBPB, Ramos AGB, Quintans JSS, Coutinho HDM, Ribeiro-Filho J, de Menezes IRA. Biological properties of terpinolene evidenced by in silico, in vitro and in vivo studies: A systematic review. Phytomedicine. 2021;93:153768. PMID: 34634744.
29. Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364. PMID: 21749363.

RSO Sublingual Oil Formula: The Complete Open-Source Recipe

This is the exact formula we manufacture. Use it to make informed purchases or to create your own version.

Cannabinoid	Amount (mg)	% of Total
CBD	4,500	27.1%
CBG	3,000	18.1%
Delta-8 THC	6,000	36.2%
THCa	1,500	9.0%
Delta-9 THC	90	0.5%
CBN	750	4.5%
CBC	750	4.5%
Total	16,590	100%

• Concentration: 553mg total cannabinoids per mL
• Volume: 30mL (1 fl oz)
• Carrier: Organic MCT oil
• Terpenes: 5% live terpene blend (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Price: $129.99

RSO Vape Cartridge Formula

Cannabinoid	% of Total
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%
Live Terpenes	5%+

• Total cannabinoids: 900mg+ per 1g cartridge
• Threading: 510 universal (works with standard vape batteries available in Grayson County)
• Price: $49.99

Terpene Profile (Same for Both Products)

• Limonene: Citrus-bright, mood-lifting
• Myrcene: Earthy, relaxing
• Caryophyllene: Pepper/spice, CB2 activation
• Pinene: Forest-fresh, clarity
• Linalool: Floral/lavender, calming
• Humulene: Earthy/woody, anti-inflammatory
• Terpinolene: Piney/fruity, complex

For Grayson County residents who know the smell of fresh-cut pine, blooming wildflowers, and summer citrus, these terpenes create a sensory experience that connects to the land you love.

Closing Thoughts for Grayson County

We wrote this guide because we know what it’s like to be let down by the system. To lose hope. To watch someone you love suffer. To search desperately for answers when conventional medicine says there are none.

We started OilWell Cannabis not in a boardroom, but in a living room with a paralyzed dog who wasn’t ready to die. That same love and determination went into every formula we’ve developed since — for Bentley, for Colin’s PTSD, for the veterans we serve, and now for you in Grayson County.

We’re not here to sell you snake oil. We’re not here to sell you hope. We’re here to give you the best possible version of the information — grounded in real science, anchored in real citations, tested in real labs — so you can give it a fair shot and decide for yourself whether it’s right or wrong for you.

If you’re in Grayson County dealing with chronic pain, cancer, PTSD, insomnia, or any condition that’s stolen your quality of life, we see you. We respect you. And we’re here to help you make an informed decision.

Contact us:

• Phone: (832) 416-2816
• Email: [email protected]
• Website: https://oilwellcbd.com/
• Instagram: @oilwellcbd

We’re a Houston-based company, but through shipping, we can serve Grayson County. We can serve Kentucky. We can serve anyone who needs what we’ve learned.

Bentley got up and walked. We hope our RSO can help you do the same.

References for the Rick Simpson Section

RS1. Simpson R. Phoenix Tears: The Rick Simpson Story. Simpson RamaDur LLC; 2012.
RS2. Laurette C, director. Run From The Cure: The Rick Simpson Story . 2005. Distributed via phoenixtears.ca and online platforms.
RS3. Simpson R. Instructions and dosing information published on phoenixtears.ca. Multiple dates. Accessed March 2026.
RS4. Velasco G, Sánchez C, Guzmán M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer. 2012;12(6):436-444. PMID: 22555283.
RS5. Guzmán M, Duarte MJ, Blázquez C, et al. A pilot clinical study of delta-9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer. 2006;95(2):197-203. PMID: 16804518.
RS6. National Cancer Institute. Cannabis and Cannabinoids (PDQ) — Health Professional Version. NIH/NCI. Updated 2024. Available at: https://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq

Final Note for Grayson County: This document represents everything we know about Rick Simpson Oil, cannabinoid science, and our specific formulas. We’ve included every detail, every citation, every warning because you deserve complete information. Whether you buy from us or use our open-source formulas to make your own, we’re honored to be part of your journey toward better health.

From our family to yours in Grayson County — be well.